MILAN (AIMnews.it) – Half-yearly revenues of 2.7 million euros for Kolinpharma, which a year earlier was 1.4 million euros. The number of prescriptions is increasing year by year, from 121.319 to 180.836, up 49%. The network of medical informants has also strengthened. On June 30th there were 67, different from the 31st December 2017, which was 37. “We are extremely satisfied with the results achieved in this first half that show how our path of growth and development is bringing tangible results – comments Emanuele Lusenti, CEO of the company -. The double-digit growth of all the main economic indicators is further confirmation of the great potential of the reference market in which we operate and which we want to better effectively monitor. As shown in the Admission Document, Kolinpharma’s revenues are linked to the seasonality of the orders and do not consistently contribute to the operating results.”